Mitochondrial Dysfunction and Chronic Liver Disease

Mitochondrial Dysfunction and Chronic Liver Disease

Mitochondria are generally considered the powerhouse of the cell, a small subcellular organelle that produces most of the cellular energy in the form of adenosine triphosphate (ATP). In addition, mitochondria are involved in various biological functions, such as biosynthesis, lipid metabolism, oxida...

Full description

Bibliographic Details
Main Authors:	Chunyan Zhang, Yabin Zhao, Mengli Yu, Jianru Qin, Bingyu Ye, Qiwen Wang
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Current Issues in Molecular Biology
Subjects:	mitochondrial dysfunction drug-induced liver injury alcoholic fatty liver non-alcoholic fatty liver hepatocellular carcinoma viral hepatitis
Online Access:	https://www.mdpi.com/1467-3045/44/7/218

Similar Items

Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
by: Ji-Qiao Zhu, et al.
Published: (2024-04-01)

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
by: Shang-Chin Huang, et al.
Published: (2023-04-01)

Liver diseases: Perspective from the Philippines
by: Eric David Ornos, et al.
Published: (2023-05-01)

Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01)

Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease
by: A. Lum Han, et al.
Published: (2022-07-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Editorial: Liver diseases and programmed cell death
by: Peng Cao, et al.
Published: (2023-03-01)

Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort studyResearch in context
by: Chao Chen, et al.
Published: (2024-02-01)

Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort
by: Wei-Chun Cheng, et al.
Published: (2024-01-01)

Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
by: Tae Seop Lim, et al.
Published: (2023-07-01)

Molecular mechanisms of autophagy and implications in liver diseases
by: Yuankai Wu, et al.
Published: (2023-03-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
by: Gi-Ae Kim, et al.
Published: (2023-12-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)

Journey of Natural Killer Cells and their Role in Liver Diseases
by: Archana Buch, et al.
Published: (2022-04-01)

Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review
by: Miren García-Cortés, et al.
Published: (2023-12-01)

Occult liver disease: A multinational perspective
by: Paulina Vidal-Cevallos, et al.
Published: (2024-05-01)

Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years
by: Ting-Chun Chen, et al.
Published: (2024-04-01)

Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation
by: Kristoffer Kjærgaard, et al.
Published: (2024-03-01)

Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
by: Kalliopi Zachou, et al.
Published: (2023-08-01)

Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
by: Ito T, et al.
Published: (2023-03-01)

Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
by: Thanaput Kunlayawutipong, et al.
Published: (2024-03-01)

Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
by: Yumin Wang, et al.
Published: (2024-01-01)

Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Jessica M. Rubino, et al.
Published: (2025-01-01)

Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)

From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria
by: Ricardo Amorim, et al.
Published: (2023-04-01)

Steatosis, inflammation, fibroprogression, and cirrhosis in remnant liver post‐liver donation
by: Jeby Jacob, et al.
Published: (2024-08-01)

Steatohepatitises: etiological variants, principles of diagnosis and management
by: D. T. Dicheva, et al.
Published: (2022-04-01)

Long-term outcomes following hepatectomy in patients with lean non-alcoholic fatty liver disease-associated hepatocellular carcinoma versus overweight and obese counterparts: A multicenter analysis
by: Wei Zhang, et al.
Published: (2025-01-01)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
by: Carlo Smirne, et al.
Published: (2020-11-01)

Liver diseases in the general population – the importance of active screening
by: Mária Beloviová, et al.
Published: (2023-09-01)

The Role of <i>Bifidobacterium</i> in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies
by: Gabriel Henrique Hizo, et al.
Published: (2023-12-01)

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
by: Byeong Geun Song, et al.
Published: (2023-09-01)

Differentiation between alcohol-associated cirrhosis and hepatitis B-associated cirrhosis based on hepatic complications and psychological symptoms
by: Yun-Fang Liang, et al.
Published: (2023-01-01)

Associations of non‐alcoholic fatty liver disease and cirrhosis with liver cancer in European and East Asian populations: A Mendelian randomization study
by: Yunyang Deng, et al.
Published: (2024-01-01)

Clinical Significance of Serum Bile Acid Profiles in Fatty Liver
by: Sun HY, et al.
Published: (2024-12-01)

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01)

Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
by: Kyung-Soo Kim, et al.
Published: (2023-03-01)

The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
by: George Chen, et al.
Published: (2023-02-01)